Phosphorus Binder Schedule for CKD Cats

When phosphate binders are needed, what the IRIS targets are at each stage, why timing with food is the single most important rule, and what to know about the aluminum toxicity controversy. Anchored to IRIS 2023, ISFM, and peer-reviewed feline medicine.

Why hyperphosphatemia matters

Phosphate is not just a number on a lab report. High serum phosphate is one of the strongest independent predictors of mortality in feline CKD.

• Boyd et al. (JVIM 2008) studied 211 cats with CKD. Each 1 mg/dL rise in serum phosphorus increased the risk of death by 11.8 percent, independent of stage [5].
• Elliott et al. (JSAP 2000) showed cats fed a phosphate-restricted diet survived a median 633 days versus 264 days on a maintenance diet. 76 percent of restricted cats had decreasing phosphate levels versus 62 percent of unrestricted cats showing increases [3].
• Geddes et al. (JVIM 2015) demonstrated that plasma FGF-23 is an independent prognostic biomarker: a 10-fold rise corresponded to a 289 percent increase in 12-month progression odds. Cats with FGF-23 above 10,000 pg/mL had roughly 4 times the mortality risk [6].

The mechanism: high phosphate triggers FGF-23 release from bone, which drives renal calcium loss, secondary hyperparathyroidism, and tubular damage. Controlling phosphate slows the entire cascade. ISFM 2016 puts it simply: with phosphate-restricted diet and intestinal binders, "progression of CKD and the degree of hyperparathyroidism in cats may be reduced" [2].

The IRIS phosphate targets

IRIS 2023 publishes stage-specific targets [1]:

IRIS 2023 added FGF-23 as an adjunct: if serum phosphate sits at the stage-3 target (less than 5 mg/dL), an FGF-23 above 700 pg/mL signals a need for further restriction, while FGF-23 below 500 pg/mL indicates excellent mineral-bone control [1].

The treatment order: diet, then binders

Both IRIS and ISFM are explicit. Phosphate binders are second-line, used "where diet alone is insufficient" to reach the stage-specific target [1, 2]. The sequence:

1. Diagnose IRIS stage. Establish baseline phosphate.
2. Transition to a renal (phosphate-restricted) diet. Allow 2 to 4 weeks for acceptance.
3. Recheck phosphate at 4 to 6 weeks [7].
4. If above target, add a phosphate binder. Recheck phosphate in another 4 weeks [3].
5. Once stable, monitor every 2 to 4 months [3].

The most important rule: binders go with food

If your cat eats two meals a day, you give half the binder dose at each meal. If your cat grazes, your vet may recommend mixing the binder into the food and offering small portions throughout the day. Giving the binder dose all at once, away from food, wastes the drug.

The available binders

Aluminum hydroxide (historically first-line)

Dose: 30 mg/kg every 8 hours or 45 mg/kg every 12 hours with food, starting around 90 mg/kg/day total, then titrated to serum phosphate [2, 3].

Mechanism: aluminum binds dietary phosphate in the gut to form insoluble, non-absorbable aluminum phosphate precipitates. Aluminum salts are the most potent phosphate binders available [3].

Most common side effect: constipation, often requiring lactulose co-therapy [3, 4].

Calcium-based binders (calcium carbonate, calcium acetate)

Calcium carbonate: 30 mg/kg every 8 hours or 45 mg/kg every 12 hours with meals, around 90 mg/kg/day starting [3]. Less potent than aluminum and binds best at acidic pH, losing efficacy in the more neutral mid-gut.

Calcium acetate: 20 to 40 mg/kg per meal. Roughly twice the binding capacity of calcium carbonate per unit calcium and causes less hypercalcemia [3].

Risk: hypercalcemia. ISFM advises monitoring ionized calcium (not just total) when a cat is on a calcium-containing binder; risk rises sharply if calcitriol is co-administered [2].

Lanthanum carbonate (Fosrenol, Renalzin)

Dose: 12.5 to 25 mg/kg/day starting; cats often need 35 to 50 mg/kg/day; IRIS range 30 to 90 mg/kg/day. GI absorption is negligible (around 0.00005 percent of the oral dose) [3].

Renalzin (lanthanum carbonate octahydrate liquid suspension, 2 mL on food once or twice daily) showed improved serum phosphorus control and quality-of-life scores versus renal-diet-only comparator [2, 3]. Main side effect: vomiting.

Chitosan plus calcium carbonate (Ipakitine, Epakitin)

Composition: 8 percent chitosan, 10 percent calcium carbonate, 82 percent lactose. Dose: 1 g per 5 kg twice daily mixed with food [3].

In a 56-day study of cats with experimentally induced CKD (more than 90 percent renal mass reduction), Epakitin significantly decreased serum phosphorus and plasma PTH versus maintenance diet alone [3]. Hypercalcemia has been observed in some treated cats because of the calcium carbonate component; monitor ionized calcium.

Sevelamer

Dose: 33 to 54 mg/kg every 8 hours or 50 to 80 mg/kg every 12 hours with meals; IRIS 90 to 160 mg/kg/day [2, 3]. Non-absorbed organic polymer with no aluminum or calcium content.

Rarely used in feline practice due to cost, larger required doses, and side effects: constipation, impaired fat-soluble vitamin absorption, and metabolic acidosis with the HCl form. The carbonate form is buffered [2, 3].

Monitoring after starting a binder

• 4 weeks after starting or adjusting a binder: recheck serum phosphate. Add ionized calcium if on a calcium-containing binder [3, 7].
• Once stable in target range: every 2 to 4 months [3].
• If on aluminum hydroxide long-term: discuss with your vet whether a serum aluminum check is appropriate [4].
• FGF-23, when available: useful for fine-tuning when phosphate is in target but progression seems faster than expected [1, 6].

Common side effects

Drug interactions to know about

Phosphate binders are non-selective chelators in the gut. They bind other oral medications too. Kidder and Chew specifically caution that other oral drugs should be administered 1 to 3 hours apart from the binder to avoid reduced absorption [3]. Drugs of particular concern:

• Fluoroquinolone antibiotics (enrofloxacin, marbofloxacin).
• Tetracyclines (doxycycline).
• Thyroid hormones (levothyroxine).
• Some heart medications.

If your cat takes multiple oral medications, work with your vet on a schedule that separates them by 1 to 3 hours from the binder dose.

Tracking binders and phosphate so the regimen actually works

The two most common failure modes for phosphate binders are timing (giving them away from food) and palatability rejection (the cat eating around the food with binder mixed in). Both look the same on a follow-up phosphate lab: numbers not coming down. Tracking each dose, with each meal, separates "the binder is not working" from "the binder is not actually getting in."

Remewdy is a free iPhone app that logs each meal, each binder dose, and each phosphate lab result in one tap. The compliance heat map shows the last 4 to 12 weeks at a glance. Premium users print a PDF for the vet that combines the binder schedule, phosphate trend, weight, and renal-diet adherence.

The app does not prescribe binders, choose between aluminum and lanthanum, or interpret bloodwork. It does the boring part: keeping the record straight so your vet can do the medical part well.